Gao, H.L. et al. 2026. Long-Term Disease-Free Survival After Sorafenib-Combined Chemotherapy for Refractory Metastatic Testicular Germ Cell Tumor: A Five-Year Follow-Up. Journal of Medical Cases. 17, 2 (Jan. 2026), 54–61. DOI:https://doi.org/10.14740/jmc5235.